iShares LifePath Target Date 2045 ETF
ITDE
0 hedge funds and large institutions have $0 invested in iShares LifePath Target Date 2045 ETF in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
40.92% less ownership
Funds ownership: 40.92% → 0% (-41%)
100% less funds holding
Funds holding: 2 → 0 (-2)
100% less capital invested
Capital invested by funds: $1.35M → $0 (-$1.35M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$822K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$524K |
ITDE Hedge Fund Activity: Q1 2024 in Review
0 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in iShares LifePath Target Date 2045 ETF (ITDE) for Q1 2024, worth a combined $0 — down 100% from $1.35M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of ITDE and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was BlackRock, exiting entirely with an estimated $822K sold.
- 0 institutional investors held iShares LifePath Target Date 2045 ETF (ITDE) as of Q1 2024, down from 2 in Q4 2023.
- Funds reported $0 of iShares LifePath Target Date 2045 ETF stock for Q1 2024, down 100% quarter-over-quarter.
- 0 funds opened new iShares LifePath Target Date 2045 ETF positions in Q1 2024 and 2 closed out, a net change of -2 holders.
- The largest iShares LifePath Target Date 2045 ETF seller in Q1 2024 was BlackRock, an estimated $822K sold.
Based on aggregated 13F filings for Q1 2024.